key: cord-0817432-8w5wqudn
authors: Sonnleitner, Sissy Therese; Sonnleitner, Stefanie; Hinterbichler, Eva; Halbfurter, Hannah; Kopecky, Dominik B.C.; Koblmüller, Stephan; Sturmbauer, Christian; Posch, Wilfried; Walder, Gernot
title: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro
date: 2022-01-29
journal: Virol Sin
DOI: 10.1016/j.virs.2022.01.029
sha: 04abf4b7c0ba6d375fde25f3b7669e516d9d52ad
doc_id: 817432
cord_uid: 8w5wqudn

Since its outbreak in 2019, Severe Acute Respiratory Syndrome Coronavirus 2 keeps surprising the medical community by evolving diverse immune escape mutations in a rapid and effective manner. To gain deeper insight into mutation frequency and dynamics, we isolated ten ancestral strains of SARS-CoV-2 and performed consecutive serial incubation in ten replications in a suitable and common cell line and subsequently analysed them using RT-qPCR and whole genome sequencing. Along those lines we hoped to gain fundamental insights into the evolutionary capacity of SARS-CoV-2 in vitro. Our results identified a series of adaptive genetic changes, ranging from unique convergent substitutional mutations and hitherto undescribed insertions. The region coding for spike proved to be a mutational hotspot, evolving a number of mutational changes including the already known substitutions at positions S:484 and S:501. We discuss the evolution of all specific adaptations as well as possible reasons for the seemingly inhomogeneous potential of SARS-CoV-2 in the adaptation to cell culture. The combination of serial passage in vitro with whole genome sequencing uncovers the immense mutational potential of some SARS-CoV-2 strains. The observed genetic changes of SARS-CoV-2 in vitro could not be explained solely by selectively neutral mutations but possibly resulted from the action of directional selection accumulating favourable genetic changes in the evolving variants, along the path of increasing potency of the strain. Competition among a high number of quasi-species in the SARS-CoV-2 in vitro population gene pool may reinforce directional selection and boost the speed of evolutionary change.

Phylogenetic relationships among the distinct viral genomes were inferred based on maximum 161 likelihood in the IQ-Tree plugin (Nguyen et al., 2015) of PhyloSuite . Indels were 162 coded as binary characters using the "simple indel coding" algorithm (Simmons and Ochoterena, 163 2000) as implemented in 2matrix (Salinas and Little, 2014) . We employed the best-fit model of 164 molecular evolution (HKY+F+I), as inferred under the Akaike information criterion using 165

ModelFinder (Kalyaanamoorthy et al., 2017) in PhyloSuite, and statistical support for nodes in the tree 166 was assessed via ultrafast bootstrapping with 5,000 replicates (Hoang et al., 2018) . Pairwise distances 167 (mean number of substitutions per site) among and within strains were inferred in MEGA X and 168 translated into substitution rates (mean substitutions per site per year) using the info on sampling time. 169

The substitution rate was calculated as divergence rate/2. 170

All mutations described here are those resulting in a change in the amino acid sequence and 171 include non-synonymous substitutions (aa substitutions), deletions and insertions. 172

Dichotomous data were evaluated for statistical significance by a chi-squared test or Fisher's exacta in 174 the case of small group size (n < 60) (Microsoft® Excel®, Microsoft 395 MSO, Windows 10). A two-175 sided significance level of P = 0.05 was used for determining statistical significance. 176

The strains were isolated from human swabs in the first pandemic wave in a routine laboratory in East 179

Tyrol/Austria with a within group mean distance of 2.6 × 10 −4 (Ct 10) between the ten strains in the 180 beginning of the experiment at passage 0. The overall mean distance between all strains of passage (P) 181 0 and the reference genome of Wuhan was calculated with 4.4 × 10 −4 , which translated to a 182 substitution rate of 6 × 10 −4 substitutions per site per year. All strains were D614G variants. 183

The pairwise distances between the diverse strains and the reference genome Wuhan are shown in 184   Table 1 . The SARS-CoV-2 strain with the lowest distance (2.0 × 10 −4 ) was A893 at the beginning of 185 the experiment and A6137 was the strain with the largest evolutionary distance of 5.4 × 10 −4 in 186 comparison to the reference genome Wuhan-Hu-1. 187

In the course of the serial passages of the ten strains, the overall mean distance between the 188 strains in P10 and the reference genome increased to 6.8 × 10 −4 during the study period, implying a 189 substitution rate of 4.8 × 10 −4 nucleotide substitutions per site per year. The pairwise distance between 190 all strains at the time point P0 and the time point P10 (intermediate time = four months) amounted to a 191 pairwise distance of 4.4 × 10 −4 and a substitution rate of 6.6 × 10 −4 . The within group mean distance in 192 P0 was 2.5 × 10 −4 , and increased to 5.6 × 10 −4 in P10, which in turn corresponded to a substitution rate 193 of 4.7 × 10 −4 . 194

The ten strains developed differently throughout the study period of four months and ten passages, 196 respectively. The three strains B4926, B5155 and B5845 did not show clear cytopathic effects in the 197 first two passages and stopped replicating after passage three, confirmed by negative PCR-results. The 198 other seven strains managed to replicate in cell culture over the entire time and achieved very low values of 8 in RT-qPCR, corresponding to a very high viral load of about 1.1 × 10 7 PFU/mL. A 200 detailed overview of the passaged strains and the different substitution rates throughout the in vitro 201 passages is given in Table 2 . 202

The substitution rates per year within the strains were between 1.0 × 10 −4 in B4926 and 6.3 × 10 −4 203 in A6137. On the inter-strain level, the substitution rates ranged from 4.9 × 10 −4 up to 1.0 × 10 −3 . The 204 between group mean distances of the strains after ten passages in cell culture are shown in Table 3 . 205

The between group mean distances were calculated in comparison to the reference genome of Wuhan. 206 A818 and A6137were the strains with the lowest and highest divergence rates, respectively, with a 207 pairwise distance of 3.3 × 10 −4 , corresponding to an evolutionary rate of 7.1 × 10 −4 nucleotides per site 208 per year. 209

Sequencing was carried out at passage 0, 3, 5, 7 and 10 respectively, exclusively high quality 211 sequences were used for further analysis and resulted in 49 SARS-CoV-2 whole genome sequences 212 with 29,896 nucleotide sites each and enabled to investigate the chronology of the emergence of the 213 individual mutations. The phylogenetic relationships of the ten strains at their different stages in the 214 course of the serial passages are shown in Fig. 1 . A6137 has developed furthest from the reference 215 genome Wuhan-Hu-1 with an astonishingly high evolutionary rate of 1.0 × 10 −3 nucleotides per site 216

per year with nine acquired non-synonymous substitutions and an interesting deletion at nucleotide 217 site 9797-9813 (aa position ORF8:A65-). 218

It is noteworthy that the majority of the non-synonymous mutations occurred after passage four. While 220 the average substitution rate for P1 to P4 was 8.1 × 10 −4 , this rate rose sharply to 1.6 × 10 −3 nucleotides 221 per site per year in P5 to P10. A summary of all substitutions is given in Fig. 2 . 222

The initial load in all ten strains was adjusted to a Ct of 10 in E-gene screening PCR, which was 224 equivalent to 1 × 10 7 PFU/mL according to our virus titration (Sonnleitner et al., 2021) . After ten 225 passages, three strains were negative in RT-qPCR and had already stopped replication within the first 226 J o u r n a l P r e -p r o o f four passages. Four strains retained their viral loads without significant titer change whereas three 227 strains could increase their abilities to reproduce in cell culture significantly and yielded high copy 228 numbers, up to an increase of 4 × 10 3 % up to 3 × 10 4 %. The detailed quantitative development of the 229 ten strains is shown in Table 4 and Fig. 2 . 230

The increased replication success in vitro seems to be associated with an increased number of 231 substitutions. Whereas the unsuccessful strains did not evolve aa substitutions, the most successful 232 strains showed the largest number of acquired permanent substitutions and temporary mutational 233 changes, respectively (2/3). The strains B5155, B4926 and B5845 did not manage to replicate in cell 234 culture and did not evolve any aa substitutions or deletions. The strains A607, A818, A893 and A6301 235 managed to stay in culture during the three-month study period with a notable decrease or increase of 236 viral load and showed a moderate number of aa substitutions. The three strains with a significant 237 increase in viral load (A7326, A6137, A4707) showed larger numbers of mutations including 238 temporary mutations, which occurred once or twice but had not been preserved. The four strains with 239 low replication success evolved between two and six aa substitutions [mean = 4; standard deviation 240 (SD) = 1.6], whereas the highly successful strains developed six to seven substitutional mutations 241 (mean = 6.7, SD = 0.6), not including temporary mutations, which would increase to seven to twelve 242 mutations during the same investigation period (mean = 9.3; SD = 2.5). Most of the genetic changes 243 occurred in the genomic regions of spike and ORF1a. Table 5 gives a clear list of all acquired 244 mutations during the experiment. Almost all genetic changes (5/7, 71.4%) that took place in A607 245 strain were recorded as temporary mutations in the closest related strain A4707. In contrast to strain 246 A607, however, additional seven mutations developed in A707 (ORF1a: A1352V; S:H66R; S:E96G; 247 S:N81T; S:D215A; ORF3a: M1I; E:S6L). A607 developed one substitution (E:V58A) that was not 248 present in A4707 and one temporary insertion (S: 22116-AAAAAGTCTACT -22117).Not all strains 249 developed substitutions in cell culture, but some evolved convergently in three or even four strains. 250 S:E484D was the substitution which occurred four times independently in the strains A818, A893, 251 A6301 and A6137. E:S6L and S:S247R developed three times convergently in the most successful 252 strains A7326, A6137 and A4707. Other substitutions developed twice in diverse strains, as shown in 253 Table 5 and Fig 3. A number of substitutions (n = 20) were already included in some or all of the 254 strains at P0 and were conserved over the full distance of the ten passages (Fig 3) . 255

Not all strains developed aa substitutions, but we could prove substitutions that developed 256 convergently in two or even three strains in the course of the serial passage (Table 3 , Fig. 4 ). The two 257 aa substitutions S:S247R and E:S6L evolved convergently in all three most successful strains. One 258 additional convergent substitution is found in the region ORF1a, seven in the spike-coding region and 259 one each in the regions ORF3a, M and ORF8. Interestingly, two of these independent mutational 260 changes occurred at the prominent positions Spike 484 and Spike 501, which are well-known in 261 connection with immune-escape variants. In our case, however, the changes were E484D (from 262 glutamic acid E to aspartic acid D instead of lysine K in variants of concern) and N501T (from 263 asparagine N to threonine T instead of tyrosine Y). 264 S:E484D developed independently three times in strains A818, A893 and A6137. Also the 265 mutations S:S247R and E:S6L were observed to develop convergently threefold in the highly 266 successful strains A7326, A4707 and A6137. The following convergent substitutions were observed in 267 two strains: S:N81T S:N501T, ORF1a:A1679V, M:H125Y and ORF8:P36L in strains A607 and 268 A4707 and S:H66R, S:E96G, S:R1091C and ORF3a:M1I in strains A7326 and A4707. 269

Strains A607, A7326, A4707 and A6137 were those with the highest numbers of convergent 270 substitutions and those with the highest evolutionary rate. None of the convergent substitutions arose 271 in one of the unsuccessful strains which did not manage replication throughout the full length of the 272 ten in vitro passages. All strains with convergent substitutions survived in all ten passages. The strains 273 A7326, A4707 and A6137 were also those with the highest growth factor and could increase the 274 starting number of PFL/mL by 79,000, 170,000 and 350,000%, respectively (Fig. 2) . 275

Only one aa deletion was found and concerned the lack of the amino acid at position 65 in the segment 277 coding for ORF8 (ORF8:A65-). This deletion was detected in two strains (A818 and A6137). 278

A noticeable change in the genetic structure of SARS-CoV-2 during serial passage in vitro came in the 280 form of insertions. These additional nucleotide sequences developed in four of the ten strains in the 281 course of the evolutionary adaptation to the cell culture. A detailed list of the strains with their 282 individual insertions as well as the position and translation into the amino acid code is given in Table  283 6. 284

In this study, we cultivated ten patient-derived Wuhan-near strains over ten in vitro passages. We 286 inoculated SARS-CoV-2 onto a primate cell culture. To afford the virus with ample opportunity for 287 adaptation, we consequently performed ten serial passages under constant conditions. Subsequently, 288

we investigated the development of all ten strains using RT-qPCR and whole genome sequencing. The 289 questions we were looking to answer were 1) whether all strains develop similarly 2) whether and how 290 the environmental change was manifested genetically and 3) the genetic locations of the acquired 291 mutations. Also, we were trying to further our understanding about each SARS-CoV-2 strain's 292 potential to evolve into a variant of concern. 293 Interestingly, the development of the ten comparable ancestral strains was very different. Three slightly lower evolutionary rate in vitro. Nonetheless, the three most successful strains were able to 300 catch up with the wildtype virus in vivo and achieved rates of 8 × 10 −4 to 9 × 10 −4 substitutions per site 301

per year. The temporary mutations of the strains A6137 and A4707 were not included in this 302 calculation of the substitution rates, which would increase the rate of evolution slightly. The twenty 303

SNPs in comparison to the reference genome Wuhan-Hu-1, which the strains already had accumulated 304 at the time of isolation, were maintained. A variety of substitutions occurred, and most of them in the 305 three most successful strains, and none earlier than after four passages. Not all the strains developed 306 substitutions. But there were two aa substitutions which occurred in all three highly successful strains. 307

Other SNPs developed convergently in two or even three strains in the course of the serial passages. 308

One of these convergent substitutions was found in the region ORF1a, seven in the spike-coding 309 region and one each in the regions ORF3a, E, M and ORF8. 310

The SNPs which occurred convergently in three different strains were located in the genetic 311 region coding for spike at amino acid positions 247 and 484, as well as position 6 of the region coding 312 for the envelope proteins. SNP 247 is located in the N-terminal domaine (NTD) of spike 1 (S1) 313 (Franco-Muñoz et al., 2020; Rohaim et al., 2021) and leads to the conversion of the original amino 314 acid S serine to R arginine. The mutation on the position S:484 is a substitution in the RBD, which 315 was described to impair neutralization resistance (Greaney et al., 2021) . It is known to be an immune 316 escape mutation when conversing from glutamine acid E to lysine K. This adaptation even developed 317 four times. None of those were in any relation to each other. In our study, all four conversions 318 occurred to aspartic acid D. They did however show their immune escape capability by resisting each 319

of the four convalescent sera tested (Liu et al., 2021; Harvey et al., 2021) . Another convergent point 320 mutation occurred in the genomic region coding for the envelope E and was found in all three most 321 successful strains of our experiment, A7326, A6137 and A4707. Five different substitutions that 322 evolved twice in different strains were found in the region coding for spike: S:H66R, S:N81T, 323 S:E96G, S:R1091C and notably, S:N501T. At exactly this position, an immune escape mutation has 324 already been described in no less than four variants of concern. Those four are the Alpha (B.1.1.7), the In our experiment, ten out of 25 substitutions (40%), which were acquired after host change into 331 cell culture, occurred in the genetic region coding for spike. The spike glycoprotein mediates viral 332 entry into the host cell via the membrane-bound angiotensin-converting enzyme 2 (ACE2) and 333 therefore, plays an important role in SARS-CoV-2 infectivity and transmissibility (Walls et al., 2020; 334 Majumdar and Niyogi, 2021, Walls et al., 2020; Majumdar and Niyogi, 2021) . This suggests that even 335 J o u r n a l P r e -p r o o f in our artificial setting in vitro, where no large accumulation of active specific antibodies is to be 336 expected, the spike region represents a mutational hotspot. Modifications in the amino acid structure 337 can also present a decisive fitness advantage in this environment. The second most common 338 substitutions were found in ORF1ab in our study (n = 9; 7 of it in ORF1a). ORF1ab (open reading 339 frame) is subdivided into ORF1a and ORF1b and encodes for nine nonstructural proteins (Franco-340 Muñoz et al., 2020) . The regions with the highest frequency of mutations were found in the sections 341 coding for the non-structural protein (nsp) 2 and nsp3. They are substantive components for viral 342 replication (Kim et al., 2020; Rohaim et al., 2021; Majumdar and Niyogi, 2021) . The substitution at 343 position ORF1a:A1679V is located in nsp3 and evolved three times independently in our experiment. 344

Nsp3 is a large, multi-domain transmembrane protein with a number of activities. Those include the 345 aforementioned participation in the viral replication, interaction with the nucleocapsid N protein, 346 promotion of cytokine expression, cleavage of viral polyprotein and blocking of host innate immune 347 response (Rohaim et al., 2021; Majumdar and Niyogi, 2021) . 348

Several unique modifications were found in the ORF1a region of the most successful strain 349 A4707, namely at positions E637A, S966F, A1397V and P1472S, all of which are located in the 350 genetic regions coding for nsp2 and nsp3 (Majumdar and Niyogi, 2021) . The remaining substitutions 351 were located at the genomic regions of ORF3a, E, M and ORF8 in one or two strains in our 352 experiment, respectively. E and M are structural proteins and encode the proteins for the viral 353 envelope and membrane (Franco-Muñoz et al., 2020; Walls et al., 2020; Majumdar and Niyogi, 2021, 354 Franco-Munoz et al., 2020; Walls et al., 2020; Majumdar and Niyogi, 2021) . ORF3a and ORF8 are 355 accessary proteins (Kim et al., 2020) . 356

ORF3a is a sodium or calcium ion channel protein encoded by the region between S and E (Lu et 357 al., 2006; Nieto-Torres et al., 2015) . It is a lineage-specific accessory protein with three 358 transmembrane domains and in combination with E it is required for viral replication and virulence 359 (Castaño- Rodriguez et al., 2018; Siu et al., 2019) . ORF8a encodes a membrane-associated structural 360 protein with a single transmembrane domain (Guan et al., 2003) . ORF8a has been proposed to 361 enhance viral replication and induce apoptosis through a mitochondria-dependent pathway (Guan et 362 al., 2003; Chen et al., 2011) . Its topology and biological function, however, remain unknown. No 363 mutational changes were observed in the regions coding for ORF3b, ORF6, ORF7ab, N, ORF9ab and 364 ORF10, suggesting that there was no selective pressure enforcing modifications in these sections. To 365 summarize, the single nucleotide substitutions took place mainly in the genetic region coding for 366 spike, which was directly required for the entry into the target cell. These substitutions may therefore 367 be considered directed mutations. 368

Furthermore, a large number of SNPs occurred in ORF1ab, a region that encodes for those non-369 structural proteins directly related to viral replication. The few other substitutions in our experiment 370 occurred in genetic regions associated with viral replication. 371 J o u r n a l P r e -p r o o f Hitherto unknown insertions occurred in our experiment in four of the ten strains and comprised 372 nine to twelve nucleotides. Two of the four insertions evolved divergently in two strains. These were 373 strain A607, a primary infection and strain A4707, isolated from the same patient in the course of a 374 febrile recurrence of the SARS-CoV-2 infections four weeks later. 375

Those two insertions were identified as codon-aligned insertions which have not been previously 376

found (Singer et al., 2020) . However, comparable insertions have been described at aa position 377 214/nucleotide position 22004 in wildtype SARS-CoV-2 strains: ins214AAG, ins214TDR and 378 ins214KLGP (Garushyants et al., 2021) The different replication success of the strains A607 and A4707 is notable as these two strains 389 were isolated coming from the same patient, once during initial infection and again during recurrence 390 three weeks later. According to phylogenetic analysis based on whole genome sequences, both strains 391 started with an apparently identical genetic framework. After ten in vitro passages, A4707 had 392 developed into one of the most successful strains with an increase of replication by 3.5 × 10 10 % 393 (Table 4) , while A607 was significantly weaker in replication. It was barely able to survive in the cell 394 culture and showed no noticeable multiplication (P < 0.05). Only one genetic difference could be 395 identified: A4707 had the insertion S:214-RQSR-215 at passage 1, whereas A607 started with a non-396 coding insertion in S:22116-AAAAAGTCTACT-22117, which was replaced by S:214-RQSR-215 not 397 earlier than passage 7. In the course of the experiment, almost all genetic changes (5/7, 71.4%) that 398 took place in the A607 strain were temporary mutations and were replaced by six novel substitutions 399 in the strain A4707. Potentially, this indicates an association between the temporary fitness 400 disadvantage of A607 in vitro and the two different spike insertions. 401

The evolutionary dynamics of RNA viruses in general are complex and may strongly be 402 influenced by their high mutation rates, rapid replication kinetics, and large population sizes (Holland 403 et al., 1982; Lauring and Andino, 2010) . The low fidelity of the viral RNA polymerase ensures the 404 constant development of point mutations, and theoretically, an immense number of different quasi-405 species is represented in a florid infection (Vignuzzi et al., 2005) . Also, an RNA virus does not consist 406 of a single strain but comprises a multitude of similar variants (Lauring and Andino, 2010) . What 407 J o u r n a l P r e -p r o o f becomes visible for us via whole genome sequencing is merely the master sequence which is 408 surrounded by a collection of quasi-species with sometimes extensive genetic heterogeneity (Nowak, 409 1992; Biebricher and Eigen, 2006; Lauring and Andino, 2010) . The comparable genetic evolution of 410 A607 and A4707 in vitro is another hint towards the quasi-species theory. We assume that a high 411 portion of the measured mutations have already been underrepresented quasi-species, arising in 412 response to the predominant environmental conditions. We see further confirmation of this theory in 413 the circumstance that the ten strains of our study evolved very differently. Not all strains in this 414 experiment, in fact, only four of ten, had the potential to develop the necessary mutational adaptations 415 to gain noteworthy fitness advantages. 416

Our experiment shows that SARS-CoV-2 is highly able to adapt to primate cell culture and changes in 418 that environment. We were especially astonished by the rapidity of some strains' adaption as well as 419 the noticeable increase in mutational change, especially in the coding region for spike, though not all 420 strains apparently carried that same potential for intensive genetic adaption. Some even abandoned 421

replication after a few passages. Others, isolated from the same patient at different times, developed 422 surprisingly similarly and evolved several convergent mutations, until the end, their only difference 423 was one insertion. 424

Since this study gives insights into the mutational adaptations of different strains of SARS-CoV-2 425 to a widely used type of cell culture, we believe it can provide a sound foundation for advanced 426 studies concerning the evolutionary dynamics of SARS-CoV-2 and other RNA-viruses in vitro. Our 427 experiments showed that high mutation rates occurred even in the absence of antibodies. These 428 mutations can be substitutions as well as insertions and deletions. Furthermore, we found convergent 429 mutations, indicating adaptation to the host change, in our case at the earliest at passage four. This 430 should be kept in mind when cultivating SARS-CoV-2, e.g. in neutralization tests in BSL-3 431 laboratories. Thusly, we propose that very early passages or recently isolated strains of SARS-CoV-2 432 should be used in diagnostic applications. In summary, the observed genetic changes of SARS-CoV-2 433 in vitro cannot be explained solely by selectively neutral mutations but possibly result from the action 434 of directional selection accumulating favourable genetic changes in the evolving variants, along the 435 path of increasing potency of the strain. Competition among a high number of quasi-species in the 436 SARS-CoV-2 in vitro population gene pool may reinforce directional selection and boost the speed of 437 evolutionary change. 438 

2.0 6 57 Female Ct P0 and Ct P10 show the Ct values of the strains at passage 0 and 10, respectively, measured by RT-653

qPCR. The growth factor shows the percentage growth of the strain during the experiment (PFU/mL at 654 P10 × 100)/(PFU/mL at P0). 655 656 J o u r n a l P r e -p r o o f Table 5 Overview of all acquired mutational changes during ten serial passages, consisting of aa substitutions, deletions and insertions. 657

A818 A893 A6301 A7326 A6137 A4707

SARS-CoV-2 escape

Genomic and proteomic mutation 465 landscapes of SARS-CoV-2'

What is a quasispecies?

Potent neutralizing antibodies from COVID-19 patients define multiple targets of 473 vulnerability

2020) 477 'Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell 478 Sequencing of Convalescent Patients' B Cells

Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and 483 Pathogenesis', mBio

485 'ORF8a of SARS-CoV forms an ion channel: experiments and molecular dynamics simulations

Indels in SARS-CoV-2 occur at template-switching 489 hotspots

Declining transition/transversion ratios through time 491 reveal limitations to the accuracy of nucleotide substitution models

Adaptive value of high mutation rates of RNA viruses: separating 494 causes from consequences

Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South 499

Insertions in SARS-CoV-2 genome 501 caused by template switch and duplications give rise to new variants that merit monitoring

Home quarantine in COVID-19: A study on 50 consecutive patients in Austria

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that 507 affect recognition by polyclonal human plasma antibodies

Isolation and characterization of viruses related to the SARS 511 coronavirus from animals in southern China

SARS-CoV-2 variants, spike mutations and immune escape

UFBoot2: 516 Improving the Ultrafast Bootstrap Approximation

Rapid 518 evolution of RNA genomes

Human neutralizing antibodies elicited by SARS-CoV-2 infection

ModelFinder: fast model selection for accurate phylogenetic estimates

Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome', Osong Public 528

Structure-guided multivalent nanobodies block SARS-CoV-2 534 infection and suppress mutational escape

MEGA X: Molecular Evolutionary 536 Genetics Analysis across Computing Platforms

Quasispecies theory and the behavior of RNA viruses

Potent 542 neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Identification of SARS-CoV-2 spike mutations that 547 attenuate monoclonal and serum antibody neutralization

Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion 550 channel and modulates virus release

SARS-CoV-2 mutations: the biological trackway towards viral 552 fitness

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody 555 escape

IQ-TREE: a fast and 557 effective stochastic algorithm for estimating maximum-likelihood phylogenies

Severe 561 acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 562 inflammasome

What is a quasispecies?

Unipro UGENE: a unified 566 bioinformatics toolkit

A deletion in SARS-CoV-2 ORF7 identified in COVID-19 outbreak 570 in Uruguay

Isolation of potent SARS-CoV-2 neutralizing antibodies and 576 protection from disease in a small animal model

Structural and functional insights 578 into non-structural proteins of coronaviruses

2matrix: A utility for indel coding and phylogenetic matrix 580 concatenation

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing 585 Antibodies with Limited Somatic Mutation

Gaps as characters in sequence-based phylogenetic 587 analyses

CoV-GLUE: A Web Application for Tracking 589 SARS-CoV-2 Genomic Variation

Severe acute respiratory syndrome coronavirus 592 ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of 593 ASC

An in vitro model for assessment of SARS-CoV-2 infectivity by 596 defining the correlation between virus isolation and quantitative PCR value: isolation success of 597 SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value

Comparative Perturbation-Based 599 Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing 600 Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted 601 by Global Circulating Mutations

Ribavirin and lethal mutagenesis of poliovirus: 603 molecular mechanisms, resistance and biological implications

Structure

Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Broad neutralization of SARS-related viruses by human monoclonal antibodies

A noncompeting pair of human neutralizing antibodies block 616 COVID-19 virus binding to its receptor ACE2

PhyloSuite: An 618 integrated and scalable desktop platform for streamlined molecular sequence data management and 619 evolutionary phylogenetics studies

SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat

Potently 628 neutralizing and protective human antibodies against SARS-CoV-2'

ORF1a ORF1a:A1679V ORF1a:D1036E ORF1a:E176G ORF1a:A1352V ORF1a:E673A ORF1a:A1352V ORF1a:F924X* ORF1a:S966F ORF1a:A1679V* ORF1a:A1397V ORF1a:P1472S ORF1 b ORF1b:E2072D ORF1b

Novel non-codon-aligned insertion S1/NTD Four of ten endemic strains of SARS-CoV-2 developed 9 to 12mer nucleotide insertions. One strain (A607) developed two different insertions sequentially. The 662 nucleotide sequences, positions and translations into amino acid codons are shown here. 663The insertion labelled with a "*" is a temporary insertion, later replaced by S:214-RQSR-215. 664 nc, nucleotide; length, nucleotide length; aa, amino acid; NTD, N-terminal domaine; S1, spike 1. 665 J o u r n a l P r e -p r o o f success is defined as the development of the viral load in the course of the experiment. All strains started with 674 viral loads of 7.6 × 10 8 . Three strains did not manage to replicate and got lost within the first three passages 675 (yellow bars), four strains maintained in culture with a decreased or nearly unchanged viral load (blue bars), 676 three strains showed significantly higher replication success (green bars). The bars show the growth factor of 677 the diverse strains, calculated as the percentage growth of the strain during the experiment (PFU/mL at P10 × 678 100)/(PFU/mL at P0). The numbers above the bars represent the acquired aa substitutions during the serial 679 passages. Numbers in parenthesis show additional temporary substitutions which did occur once in a sequence 680 throughout the experiment but were not preserved. The first three strains, here marked with the first letter B, 681 did not manage to replicate successfully in cell culture and were lost after at least four passages. Actual 682 increases, thus successful adaptation to the cell cultures, were recorded in the six strains A818 to A4707, with 683 the last three strains A7426, A6137 and A4706 achieving the highest increase in PFU/mL with growth of 4 × 684 10 3 up to 3 × 10 4 %. during serial passage of ten SARS-CoV-2 strains in vitro. All convergently evolved mutations occurred in the 704 regions coding for ORF1a/nsp3 (1); ORF3a (1), E (1), M (1), ORF8 (1) and spike (8). Substitutions marked 705 with "***" evolved convergently in all three highly successful strains.